Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2011-006107-35-BE
EUCTR2011-006107-35-BEActive, not recruitingPhase 1

Pharmacokinetics of small spectcrum beta-lactam antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) on intensive care.

Ghent University Hospital0 sites37 target enrollmentStarted: February 15, 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
37
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •- patients, hospitalised on the Intensive Care
  • •- treatment with Amoxicillin/Clavulanic acid or Cefuroxime, because of an infection.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 50
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

  • •- patients < 18 years of age
  • •- no signed informed consent
  • •- Hematocrite < 21%
  • •- no arterial catheter present

Investigators

Similar Trials

Active, not recruiting
Phase 1
Pilot study: pharmacokinetics of beta-lactam antibiotics, piperacillin-tazobactam, ceftazidim and meropenem in blood and sputum of cystic fibrosis patients.Cystic fibrosis
EUCTR2016-000398-19-BEGhent University45
Completed
Not Applicable
Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care UnitsInfection
NCT01581047University Hospital, Ghent37
Active, not recruiting
Phase 1
Dose individualization of beta-lactam and fluoroquinolone antibiotics in intensive care unit patientsICU patients with infection
EUCTR2017-004677-14-NLErasmus MC250
Not yet recruiting
Not Applicable
Dose individualization of Beta-lactam and fluoroquinolone antibiotics in ICU patients: to TDM or not to TDM and the effects on OutcomeIntensive care, Antibiotics, Pharmacodynamics, Pharmacokinetics
NL-OMON21680Erasmus MC250
Active, not recruiting
Not Applicable
optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis.hemodialysisoligoanuriasepsisMedDRA version: 14.0Level: HLTClassification code 10040054Term: Sepsis, bacteraemia, viraemia and fungaemia NECSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: LLTClassification code 10066622Term: Chronic hemodialysisSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2011-001573-10-BEHôpital Erasme